Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157 percent in Ontario from 2015 to 2023, according to a new study from researchers at ICES, North… read more.
For adults who have recovered from depression with the help of antidepressants, gradually reducing medication together with psychological support appears to be as effective as remaining on antidepressants… read more.
Children who spend longer looking at screens have more severe attention-deficit/hyperactivity disorder (ADHD) symptoms, according to Japanese scientists who studied brain development and behavioural issues. The study found… read more.
Large language models can help improve questionnaires used to diagnose mental illness by optimizing symptom generalizability and reducing redundancy. They can even contribute to new conceptualizations of mental… read more.
A rigorous systematic review of the present state of knowledge on the use of acetaminophen during pregnancy and the risk of specific neurodevelopmental disorders (NDDs), such as autism… read more.
Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person’s sense of reality. Now—just over… read more.
Hospice care aims to bring comfort, peace, and dignity to patients at the end of life. Yet for the growing number of Americans with dementia who enter hospice,… read more.
A nationwide, longitudinal study characterized how physician attrition rates from clinical practice have changed and the factors associated with a differential likelihood of attrition. The study found that… read more.
An Indiana University study brings a comprehensive new perspective to a growing body of evidence suggesting that mild to moderate use of prescribed opioid pain medications during pregnancy… read more.
Life-saving opportunities to prevent suicide among autistic people are being missed because systemic barriers make it difficult for them to access NHS support during times of mental health… read more.
-BioXcel Therapeutics, Inc announced that the SERENITY At-Home Pivotal Phase III trial evaluating the safety of BXCL 501, the Company’s proprietary, sublingual film formulation of dexmedetomidine, as an… read more.
Despite concerns about increased stimulant prescribing, nonmedical use of ADHD drugs among adolescents has declined in the last 20 years, a University of Michigan study shows. While medical… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
